AI filing briefs · archive

8-K filings in August 2026, explained

2,914 material Form 8-K filings that 2,352 companies we cover made with the SEC in August 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

9 of 2,914 briefs match

newest first · times in ET
MQMarqeta, Inc. Aug 13, 5:03 PM ET

Marqeta Chief Accounting Officer Sarah Barkema to resign effective August 21, 2026

Neutral leadership Written later 5.02

Marqeta said its Chief Accounting Officer and principal accounting officer, Sarah Barkema, will resign effective August 21, 2026, and that her departure is not due to any disagreement over financial statements, internal controls, operations, policies or practices. CFO Patti Kangwankij will take over the principal accounting officer role, and the company plans to search for a new Chief Accounting Officer.

  • Sarah Barkema informed the company of her resignation on August 10, 2026; effective date is August 21, 2026
  • The company states the departure involves no disagreement on financial statements, internal control, operations, policies or practices
  • CFO Patti Kangwankij will become principal accounting officer after Barkema leaves
  • The company intends to search for a new Chief Accounting Officer; no successor is named
Read the filing on SEC.gov ↗
BNYBank of New York Mellon Corp Aug 13, 4:31 PM ET

BNY elects Vikram Malhotra to its board, effective October 1, 2026

Neutral leadership Written later 5.02

BNY's board elected Vikram Malhotra, a senior partner at McKinsey & Company, as an independent director, effective October 1, 2026. With his addition, the board will have 12 directors, 11 of whom are independent. The filing describes a board seat with customary non-management director compensation and does not report any change to executive officers.

  • Board elected Malhotra on August 11, 2026, effective October 1, 2026
  • Board will consist of 12 directors, 11 of them independent
  • Malhotra has been a senior partner at McKinsey since 1998 and joined the firm in 1986
  • He will receive non-management director compensation as described in the March 5, 2026 proxy statement
Read the filing on SEC.gov ↗
XYLXylem Inc. Aug 13, 4:22 PM ET

Xylem Appoints D. Christian Koch, Carlisle Companies CEO, to Board of Directors

Neutral leadership Written later 5.02

Xylem expanded its Board of Directors from 9 to 10 members and appointed D. Christian Koch to fill the new seat, effective immediately on August 13, 2026. The Board determined Koch is independent, and he also joined the Leadership Development and Compensation Committee and the Nominating and Governance Committee. Koch currently serves as Chairman, President and Chief Executive Officer of Carlisle Companies Incorporated, and the filing states he will receive standard non-employee director compensation, prorated for the current term.

  • Board size increased from 9 to 10 directors; Koch appointed to fill the vacancy effective August 13, 2026
  • Koch joins the Leadership Development and Compensation Committee and the Nominating and Governance Committee
  • Board determined Koch is independent under NYSE listing standards and SEC rules
  • Koch is Chairman, President and CEO of Carlisle Companies Incorporated; compensation follows the 2026 Proxy Statement filed March 20, 2026, prorated for the current term
Read the filing on SEC.gov ↗

GrabAGun CFO Justin Hilty to retire; Jonathan Terry named CFO effective August 14

Neutral leadership Written later 5.027.01

GrabAGun Digital Holdings announced that co-founder and CFO Justin Hilty will step down as CFO effective August 14, 2026, and will stay in a transitional role until he retires on September 1, 2026. Jonathan Terry, formerly Vice President, Global Finance at YETI Holdings, takes over as CFO, principal accounting officer and principal financial officer on the same date. The filing states Hilty's decision did not involve any dispute with the company over operations, policies, practices or financial statements.

  • Justin Hilty resigns as CFO effective August 14, 2026; transitional role until retirement on September 1, 2026
  • Jonathan Terry appointed CFO effective August 14, 2026; employment began August 10, 2026
  • Terry's base salary is $400,000, with a target bonus of 60% of salary and a maximum of 120%
  • Terry received $300,000 in restricted stock units vesting in thirds on August 10, 2027, 2028 and 2029
Read the filing on SEC.gov ↗
ADUSAddus HomeCare Corp Aug 13, 4:16 PM ET

Addus HomeCare COO Heather Dixon departs; Brad Bickham returns as interim COO

Neutral leadership Written later 5.027.01

Addus HomeCare said President and Chief Operating Officer Heather Dixon left the company on August 7, 2026. The company appointed W. Bradley Bickham, its former president and COO, as interim COO on the same day, under an employment agreement that runs through July 31, 2027.

  • Heather Dixon, President and Chief Operating Officer, left the company on August 7, 2026.
  • W. Bradley Bickham, age 63, was appointed interim Chief Operating Officer on August 7, 2026.
  • Bickham's employment agreement, dated August 10, 2026, sets an annualized base salary of $622,000 plus fixed bonuses.
  • Bickham previously served as President and COO from March 2021 to September 2025 and as Advisor to the CEO from September 2025.
Read the filing on SEC.gov ↗
WYYWIDEPOINT CORP Aug 13, 4:12 PM ET

WidePoint: Chief Revenue Officer Jason Holloway to resign effective December 31, 2026

Neutral leadership Written later 5.02

WidePoint Corporation disclosed that Executive Vice President and Chief Revenue Officer Jason Holloway tendered his resignation on August 7, 2026, effective December 31, 2026. The company said the departure is for personal and family reasons and not due to any disagreement with the company.

  • Jason Holloway resigned as Executive Vice President and Chief Revenue Officer, tendered August 7, 2026.
  • Resignation is effective December 31, 2026.
  • Company states the departure is for personal and family reasons and involved no disagreement with the company.
  • The company thanked Mr. Holloway for his significant contributions.
Read the filing on SEC.gov ↗
OMEROMEROS CORP Aug 13, 4:05 PM ET

Omeros Adds Joseph Schocken as Director and Audit Committee Member

Neutral leadership Written later 5.02

Omeros Corporation's board increased its size to nine directors on August 12, 2026, and appointed Joseph Schocken as a director effective immediately. The board also named him to the Audit Committee, and he received a stock option for 30,000 shares under the company's non-employee director pay policy.

  • Joseph Schocken, 79, appointed director effective August 12, 2026; board expanded to nine directors
  • Initial term runs until the 2027 annual meeting of shareholders, or earlier resignation or removal
  • Appointed to the Audit Committee; granted a stock option for 30,000 shares of common stock
Read the filing on SEC.gov ↗
CXMSprinklr, Inc. Aug 13, 7:37 AM ET

Sprinklr Appoints Jordi Ribas, Microsoft Search & AI President, to Board of Directors

Neutral leadership Written later 5.027.01

Sprinklr expanded its board from seven to eight directors by appointing Jordi Ribas, Ph.D., President of Search & AI at Microsoft, effective August 17, 2026. The filing describes his compensation as a non-employee director, which includes equity awards valued at $200,000 each and cash retainers, and notes that director Eileen Schloss was removed from the Strategy Committee to make room for him.

  • Board size increased from seven to eight directors; Ribas appointed as a Class II director with a term expiring at the 2029 Annual Meeting
  • Initial and annual RSU awards valued at $200,000 each, plus a $40,000 base cash retainer and additional committee retainers
  • Ribas joins the Nominating and Corporate Governance Committee and Strategy Committee; Eileen Schloss removed from the Strategy Committee effective August 17, 2026
Read the filing on SEC.gov ↗
OLMAOlema Pharmaceuticals, Inc. Aug 13, 7:05 AM ET

Olema Names Jason O'Byrne Chief Financial Officer, Effective August 11, 2026

Neutral leadership Written later 5.027.01

Olema Pharmaceuticals announced on August 13, 2026 that Jason O'Byrne has been appointed Chief Financial Officer, principal financial officer and principal accounting officer, effective August 11, 2026. He most recently served as Executive Vice President and Chief Financial Officer of Vir Biotechnology from October 2024 to August 2026. The filing sets his pay, including a $545,000 initial base salary and an option for 650,000 shares that is subject to Board approval.

  • Initial annualized base salary of $545,000 and an annual bonus target of 45% of base salary
  • Sign-on bonuses of $250,000 (within 30 days of the effective date) and $100,000 (within 30 days after the first anniversary), subject to service-based repayment
  • Option for 650,000 common shares under the 2022 Inducement Plan, vesting over four years, subject to Board approval
  • Severance includes 12 months of base salary; double-trigger protection applies if termination occurs within 3 months before or 18 months after a Change in Control
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.